David A. G. Bos

David A. G. Bos

Auto-generated profile, based on publicly available information

David A. G. Bos

LUHTAR, Department of Public Health and Primary Care, KU Leuven

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
DBDavid A. G. Bos
David A. G. Bos
KLKatrien Lagrou
Katrien Lagrou
JVJan Y. Verbakel
Jan Y. Verbakel
Rapid diagnosis or exclusion of SARS-CoV-2 infection is essential for correct medical management decisions regarding COVID-19. High-throughput laboratory-based reverse transcriptase (RT)-PCR testing is accurate with longer turnaround times, while rapid antigen tests show moderate sensitivity.

8 August 2024 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
RBRuben Burvenich
Ruben Burvenich
DBDavid Ag Bos
David Ag Bos
LLLien Lowie
Lien Lowie
KPKiyano Peeters
Kiyano Peeters
JTJaan Toelen
Jaan Toelen
Jan VerbakelJan Verbakel
Jan Verbakel
Background: Safety-netting advice (SNA) can help in the management of acutely ill children. Aim: To assess the effectiveness of different SNA methods on antibiotic prescription and consumption in acutely ill children. Design and setting: Systematic review and network meta-analysis of randomised controlled trials, cluster randomised trials, non-randomised studies of interventions, and controlled before–after studies in ambulatory care in high-income countries. Method: MEDLINE, Embase, Web of Science Core Collection, and Cochrane Central Register of Controlled Trials were searched (22 January 2024). Risk of bias (RoB) was assessed with Cochrane’s RoB 2 tool, the Revised Cochrane Tool for Cluster-Randomised Trials, and the Risk Of Bias In Non-randomised Studies — of Interventions tool. Certainty of evidence was assessed using the Confidence in Network Meta-Analysis approach. Sensitivity analyses and network meta-regression were performed. Results: In total, 30 studies (20 interventions) were included. Compared with usual care, paper SNA may reduce: antibiotic prescribing (odds ratio [OR] 0.66, 95% confidence interval [CI] = 0.53 to 0.82, I 2 = 92%, very low certainty, three studies, 35 988 participants), especially when combined with oral SNA (OR 0.40, 95% CI = 0.08 to 2.00, P -score = 0.86); antibiotic consumption (OR 0.39, 95% CI = 0.27 to 0.58, low RoB, one study, 509 participants); and return visits (OR 0.74, 95% CI = 0.63 to 0.87). Compared with usual care, video SNA, read-only websites, oral SNA, and web-based SNA (in descending order of effectiveness) may increase parental knowledge (ORs 2.33–4.52), while paper SNA may not (ORs 1.18–1.62). Similarly, compared with usual care, video SNA and web-based modules may improve parental satisfaction (ORs 1.94–4.08), while paper SNA may not (OR 1.85, 95% CI = 0.48 to 7.08). Conclusion: Paper SNA (with oral SNA) may reduce antibiotic use and return visits. Video, oral, and online SNA may improve parental knowledge, whereas video SNA and web-based modules may increase parental satisfaction.

18 April 2023 in BMC Medicine
Verified
Journal Article
Open access
PDF file
DBDavid A. G. Bos
David A. G. Bos
TBTine De Burghgraeve
Tine De Burghgraeve
ASAn De Sutter
An De Sutter
FBFrank Buntinx
Frank Buntinx
JVJan Y. Verbakel
Jan Y. Verbakel
Background: Early distinction between mild and serious infections (SI) is challenging in children in ambulatory care. Clinical prediction models (CPMs), developed to aid physicians in clinical decision-making, require broad external validation before clinical use. We aimed to externally validate four CPMs, developed in emergency departments, in ambulatory care. Methods: We applied the CPMs in a prospective cohort of acutely ill children presenting to general practices, outpatient paediatric practices or emergency departments in Flanders, Belgium. For two multinomial regression models, Feverkidstool and Craig model, discriminative ability and calibration were assessed, and a model update was performed by re-estimation of coefficients with correction for overfitting. For two risk scores, the SBI score and PAWS, the diagnostic test accuracy was assessed. Results: A total of 8211 children were included, comprising 498 SI and 276 serious bacterial infections (SBI). Feverkidstool had a C-statistic of 0.80 (95% confidence interval 0.77–0.84) with good calibration for pneumonia and 0.74 (0.70–0.79) with poor calibration for other SBI. The Craig model had a C-statistic of 0.80 (0.77–0.83) for pneumonia, 0.75 (0.70–0.80) for complicated urinary tract infections and 0.63 (0.39–0.88) for bacteraemia, with poor calibration. The model update resulted in improved C-statistics for all outcomes and good overall calibration for Feverkidstool and the Craig model. SBI score and PAWS performed extremely weak with sensitivities of 0.12 (0.09–0.15) and 0.32 (0.28–0.37). Conclusions: Feverkidstool and the Craig model show good discriminative ability for predicting SBI and a potential for early recognition of SBI, confirming good external validity in a low prevalence setting of SBI. The SBI score and PAWS showed poor diagnostic performance. Trial registration: ClinicalTrials.gov, NCT02024282. Registered on 31 December 2013.